Clinipace Drives Study Startup Optimization with goBalto (PR Newswire)

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced that UF startup Clinipace has chosen goBalto’s end-to-end platform for starting clinical trials.
If you fail to plan, you are planning to fail. These words ring true when it comes to study startup, a notorious bottleneck in clinical trials. With research showing a continually stagnating timeframe for conducting clinical trials and a trend toward improving study performance, quality improvement is moving to center stage. With the availability of industry proven workflow-based goBalto Activate, proactive planning, process optimization and quality improvements with study startup – as measured by inspection-readiness and the likelihood of passing regulatory audits – are within reach.

Activate, along with goBalto Analyze, a data analytics platform – optimize the many study startup steps, providing real-time insights into study status, a vast improvement from the manual, time-consuming methods still predominantly used across the industry.

Learn more about Clinipace Drives Study Startup Optimization with goBalto.